Demand for dermal fillers in Europe market is set to grow by 4.5% from 2023 to 2033 with an estimated market value of around US$ 1.63 Billion as of 2023. As per Future Market Insights, Hyaluronic Acid segment by ingredient type held a share of about 71.4% in 2022 within the European Market
Market Outlook:
| Data Points | Market Insights |
|---|---|
| Europe Dermal Fillers Market Value 2022 | US$ 1.57 Billion |
| Market Value 2023 | US$ 1.63 Billion |
| Market Value 2033 | US$ 2.52 Billion |
| CAGR 2023 to 2033 | 4.5% |
| Market Share of Top 3 Countries | 79.5% |
Dermal fillers have become more popular in the European market as a result of rising disposable incomes and a shift in customers' attitudes towards non-surgical methods of enhancing their aesthetic appeal. These treatments are in great demand among customers because of their high level of safety and acceptable patient results.
Due to new developments in rejuvenation and cosmetic enhancements that were previously only possible through surgery, dermal fillers have seen a sharp increase in popularity recently. Dermal fillers exhibit immediate benefits in cosmetic volume restoration procedures because to their less invasive nature.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The Europe dermal fillers market recorded a historic CAGR of 2.7% in the last 10 years from 2012 to 2022. Europe dermal fillers market holds around 26.1% of the Global dermal fillers market in 2022.
The popularity of social media sites and the prominence of celebrities have raised public awareness of fashion and beauty trends. The amount of social media coverage of dermal fillers rose eightfold between 2010 and 2020. Digital messages are widely received by new patient groups; for instance, 60% of Twitter mentions are from men and people under the age of 25.
The endorsements and suggestions of many of these social influencers, who have large fan bases in Europe, affects people's tastes and decisions about cosmetic treatments like using dermal fillers. Platforms like Instagram are excellent for displaying aesthetic changes since they are very visual and image-focused. The popularity of content featuring before-and-after images and behind-the-scenes peeks at cosmetic operations has increased people's interest in and curiosity about various aesthetic procedures. Hence Europe has seen a rising demand.
Manufacturers do the same thing by maintaining active social media profiles and websites where they provide before-and-after photos, success tales, and how-to guides. By collaborating with suppliers and customers to develop cutting-edge products that will increase sales and profits for both parties, firms and manufacturers are expecting to increase their clientele. They employ an integrated approach to developing new products and processes by integrating a number of approaches into their operations.
Many companies have also formed strategic partnership with clinics and KOLs of the aesthetic industry in Europe, to promote their products and distribute the patients with the brochures of product benefits to boost the sales.
Overall, the growing popularity and promotion of dermal fillers have led to the rise in the demand in the European region.
The demand for non-invasive aesthetic procedures is increasing in Europe, which has created new business prospects for the producers of dermal fillers.
Dermal fillers are further becoming more popular in Europe as the population their ages and individuals look for ways to stay youthful. These fillers can treat volume loss, wrinkles, and sagging skin.
Dermal fillers have also demonstrated the potential to be employed in combination treatments for numerous applications. Apart from the popular application, anti-aging treatment, which has wonderful advantages, dermal fillers have a variety of other uses: The ability to mix dermal fillers with other procedures is one of its finest features. In fact, combining dermal fillers with Botox injections can produce the smoothest and natural results for face skin. Dermal fillers with Botox and Xeomin work best together to treat deeper and more pronounced wrinkles.
The customized solutions combined with the advanced formulations have led manufacturers develop marketing campaigns that resonate with different cultural preferences and age groups in different countries of Europe
Principal Consultant
The expensive procedures using dermal fillers for treating both basic and complex parts of the face and body have slowed the market's expansion. The cost of the doctor or surgeon is around 40 to 50 percent of the dermal filler price. Additionally, the whole therapy involves numerous sessions, which makes it more difficult to fund the treatment in main circumstances.
In major cases the effect of the dermal fillers is not very long lasting. With the exception of PMMA fillers, the dermal fillers that are now on the market are absorbable and biodegradable. Only 3 to 24 months are the life of these biodegradable fillers. The estimated lifespan of PMMA fillings is 4 to 5 years. As a result, the process might be repeated after a specified amount of time. Few people choose surgical face rejuvenation over dermal fillers because of this, as the results persist a long time.
These factors can pose as a potential threat to the growth of the dermal fillers market in Europe.
Germany dominates the European market of dermal fillers with 33.3% market share in 2022 and is projected to continue experiencing high growth throughout the forecast period.
Germany boasts one of the prominent economies in Europe and one of the significant living standards. A sizeable percentage of the population can now afford cosmetic procedures like dermal fillers due to this wealth. In Germany, knowledge and acceptability of cosmetic operations have grown over the past several years. The demand for non-surgical cosmetic procedures like dermal fillers has surged as a result of this change in public attitudes.
Additionally, the technological advancements and well developed healthcare systems with efficient patient care and physicians have added to the market growth.
The United Kingdom holds about 12.0% of the market share, within Europe in 2022.
A strong culture of cosmetics and beauty exists in the United Kingdom. Dermal fillers and other cosmetic operations are becoming more widely accepted as ways to improve one's look and increase self-confidence. Celebrities, influencers, and social media are all very prevalent and have a big impact on how people see beauty.
Medical tourists from other nations come to the United Kingdom to receive top-notch medical care, including cosmetic surgeries. The market for dermal fillers is expanding as a result of this inflow of foreign patients.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Hyaluronic Acid segment within the ingredient segment hold a revenue share of 71.4% in 2022, and the same trend is being followed over the forecasted period.
Hyaluronic acid is extremely biocompatible since it is a naturally occurring component in the human body. This lowers the possibility of allergic responses or other negative consequences, making it a safe choice for the majority of people. Dermal fillers' main objective is to produce outcomes that seem natural. HA fillers create slight improvements without seeming unduly artificial since they blend in perfectly with the structure of the skin.
Absorbable dermal fillers held a market share of 99.9% in 2022. Dermal fillers that dissolve naturally provide effects. They enhance features without giving an unnatural look since they blend in naturally with the skin's tissue. The body's normal metabolic activities progressively degrade them over time. This progressive deterioration minimizes the possibility of abrupt and unwelcome changes in appearance while allowing for modifications or touch-ups when necessary.
Aesthetic Restoration within the application segment hold a market share of 82.2% in 2022, within the forecasted period.
Dermal filler techniques are frequently used in aesthetic restoration because to their efficiency in treating various ageing symptoms and improving natural characteristics. the benefits of skin replenishment by boosting these regions' look and reviving them overall are the major benefits. By boosting volume under the skin's surface, dermal fillers can effectively smooth out wrinkles, fine lines, and creases. This contributes to a smoother, younger-looking appearance.
Specialty Clinics within the distribution channel segment hold a market share of 86.5% in 2022, within the forecasted period.
Due to the increasing demand for dermal filler procedures, the customized treatment plans, collaborations with major filler brands the service of these specialty clines are the best and it in turn to attract more and more customers making it the hold the significant market share.
Key manufacturers of dermal filler brands are focusing on new improved product launches and collaborations with KOLs and clinics to promote their products.
Similarly, recent developments related to companies in Europe Dermal Fillers Market have been tracked by the team at Future Market Insights, which are available in the full report.
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2012 to 2022 |
| Market Analysis | US$ Million for Value, Units for Volume |
| Key Countries Covered | United Kingdom, Germany, Spain, Italy, France, BENELUX, Nordics, and Rest of Europe |
| Key Market Segments Covered | Ingredient, Product, Application, Distribution Channel and Country |
| Key Companies Profiled | Galderma Pharma S.A; Bioscience GmbH; Croman Pharma; Allergan plc. (AbbVie); Sinclair Pharma plc. (Heading Medicine Co., Ltd); Zimmer Aesthetics; Mars Pharma GmbH & Co. Kraal; Zueva Medical, Inc.; Texan Laboratories Inc.; Adder GmbH; Polonium Medical Technologies Inc.; Intracellular Medical UK Ltd; LKC Pharma; Biloxi’s Pharmaceutical |
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Pricing | Available upon Request |
The market is valued at US$ 1.63 billion in 2023.
The market recorded a CAGR of 2.7% from 2018 to 2022.
The market is estimated to be worth US$ 2.52 billion in 2033.
The hyaluronic acid held a market share of 71.4% in 2022.
The growing preference for non-invasive procedures is likely to provide a boost to the market.
1. Executive Summary
1.1. Europe Market Outlook
1.2. Demand Side Trends
1.3. Supply-Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Development/Innovation Trends
4. Value Added Insights
4.1. Ingredient Adoption/ Usage Analysis
4.2. Regulatory Approved Dermal Fillers
4.3. Regulatory Landscape
4.4. Number of clinics conducting dermal filler treatments, By Country
4.5. Total Dermal Filler Procedures, by Country
4.6. List of Distributors/Whole Sellers
4.7. % Split of Professionals Injecting Dermal Filler
4.7.1. Doctors
4.7.2. Nurses
4.7.3. Dentists
4.7.4. Dermatologists
4.7.5. Surgeons
4.8. Consumer Sentiment Analysis
4.9. Consumer Sentiment Analysis: Ingredient Satisfaction
4.10. PESTLE Analysis
4.11. Porter’s Analysis
4.12. Value Chain Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Europe Healthcare Expenditure Outlook
5.1.2. Europe Life Expectancy Outlook
5.1.3. Research & Development Funding, By Region
5.1.4. Europe Medical Devices Market Outlook
5.1.5. Global Market Analysis
5.2. Forecast Factors - Relevance & Impact
5.2.1. Increase in Europe Healthcare Expenditure
5.2.2. Corporate Investments Helps Drive Research and Development
5.2.3. Increasing Aesthetic Awareness
5.2.4. Increasing Preference of Minimally Invasive Procedures
5.2.5. Changing Regulatory Dynamics
5.2.6. Historical Growth of Key Players
5.2.7. High Cost of Procedures
5.2.8. Per-patient Spending
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. Europe Market Volume (in Units) Analysis 2012 to 2022 and Forecast, 2023 to 2033
6.1. Historical Market Volume (in Units) Analysis, 2012 to 2022
6.2. Current and Future Market Volume (in Units) Projections, 2023 to 2033
6.2.1. Y-o-Y Growth Trend Analysis
7. Europe Market: Pricing Analysis
7.1. Regional Pricing Analysis
7.2. Pricing Break-up
7.2.1. Manufacturer-Level Level Pricing
7.2.2. End User Level Pricing
7.3. Europe Average Pricing Analysis Benchmark
7.4. Pricing Assumptions
8. Europe Market Demand (in Value or Size in US$ Million) Analysis 2012 to 2022 and Forecast, 2023 to 2033
8.1. Historical Market Value (US$ Million) Analysis, 2012 to 2022
8.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033
8.2.1. Y-o-Y Growth Trend Analysis
8.2.2. Absolute $ Opportunity Analysis
9. Europe Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Product
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) Analysis by Product, 2012 to 2022
9.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Product, 2023 to 2033
9.3.1. Absorbable
9.3.2. Non - Absorbable
9.4. Market Attractiveness Analysis by Product
10. Europe Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Ingredient
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) & Volume (Units) Analysis, By Ingredient, 2012 to 2022
10.3. Current and Future Market Size (US$ Million) & Volume (Units) Analysis and Forecast by Ingredient, 2023 to 2033
10.3.1. Hyaluronic Acid
10.3.2. Poly-L-Lactic Acid
10.3.3. Calcium Hydroxylapatite
10.3.4. Polymethyl methacrylate
10.3.5. Collagen
10.3.6. Polynucleotide (PN)
10.4. Market Attractiveness Analysis by Ingredient
11. Europe Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Application
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Million) Analysis By Application, 2012 to 2022
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Application, 2023 to 2033
11.3.1. Aesthetic Restoration
11.3.2. Dentistry
11.3.3. Reconstructive Surgery
11.4. Market Attractiveness Analysis by Application
12. Europe Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Distribution Channel
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Million) Analysis By Distribution Channel, 2012 to 2022
12.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Distribution Channel, 2023 to 2033
12.3.1. Hospitals
12.3.2. Speciality Clinics
12.3.2.1. Small
12.3.2.2. Medium
12.3.2.3. Large
12.3.3. Online Pharmacies
12.4. Market Attractiveness Analysis by Distribution Channel
13. Europe Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Region
13.1. Introduction
13.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Region, 2012 to 2022
13.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Region, 2023 to 2033
13.3.1. United Kingdom
13.3.2. Germany
13.3.3. France
13.3.4. Italy
13.3.5. Spain
13.3.6. BENELUX
13.3.7. Nordics
13.4. Market Attractiveness Analysis By Region
14. United Kingdom Market Analysis 2012 to 2022 and Forecast 2023 to 2033
14.1. Introduction
14.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Market Taxonomy, 2012 to 2022
14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
14.3.1. By States
14.3.1.1. England
14.3.1.2. Wales
14.3.1.3. Northern Ireland
14.3.1.4. Scotland
14.3.2. By Product
14.3.3. By Ingredient
14.3.4. By Application
14.3.5. By Distribution Channel
14.4. Market Attractiveness Analysis
14.4.1. By States
14.4.2. By Product
14.4.3. By Ingredient
14.4.4. By Application
14.4.5. By Distribution Channel
14.5. Drivers and Restraints - Impact Analysis
14.6. State-Level Analysis & Forecast
14.6.1. England Market Analysis
14.6.1.1. Introduction
14.6.1.2. Market Analysis and Forecast by Market Taxonomy
14.6.1.2.1. By Product
14.6.1.2.2. By Ingredient
14.6.1.2.3. By Application
14.6.1.2.4. By Distribution Channel
14.6.2. Wales Market Analysis
14.6.2.1. Introduction
14.6.2.2. Market Analysis and Forecast by Market Taxonomy
14.6.2.2.1. By Product
14.6.2.2.2. By Ingredient
14.6.2.2.3. By Application
14.6.2.2.4. By Distribution Channel
14.6.3. Northern Ireland Market Analysis
14.6.3.1. Introduction
14.6.3.2. Market Analysis and Forecast by Market Taxonomy
14.6.3.2.1. By Product
14.6.3.2.2. By Ingredient
14.6.3.2.3. By Application
14.6.3.2.4. By Distribution Channel
14.6.4. Scotland Market Analysis
14.6.4.1. Introduction
14.6.4.2. Market Analysis and Forecast by Market Taxonomy
14.6.4.2.1. By Product
14.6.4.2.2. By Ingredient
14.6.4.2.3. By Application
14.6.4.2.4. By Distribution Channel
15. Germany Market Analysis 2012 to 2022 and Forecast 2023 to 2033
15.1. Introduction
15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Market Taxonomy, 2012 to 2022
15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
15.3.1. By States
15.3.1.1. Baden-Württemberg
15.3.1.2. Bavaria
15.3.1.3. Lower Saxony
15.3.1.4. Hesse
15.3.1.5. Rest of Germany
15.3.2. By Product
15.3.3. By Ingredient
15.3.4. By Application
15.3.5. By Distribution Channel
15.4. Market Attractiveness Analysis
15.4.1. By States
15.4.2. By Product
15.4.3. By Ingredient
15.4.4. By Application
15.4.5. By Distribution Channel
15.5. Drivers and Restraints - Impact Analysis
15.6. States Level Analysis & Forecast
15.6.1. Baden-Württemberg Market Analysis
15.6.1.1. Introduction
15.6.1.2. Market Analysis and Forecast by Market Taxonomy
15.6.1.2.1. By Product
15.6.1.2.2. By Ingredient
15.6.1.2.3. By Application
15.6.1.2.4. By Distribution Channel
15.6.2. Bavaria Market Analysis
15.6.2.1. Introduction
15.6.2.2. Market Analysis and Forecast by Market Taxonomy
15.6.2.2.1. By Product
15.6.2.2.2. By Ingredient
15.6.2.2.3. By Application
15.6.2.2.4. By Distribution Channel
15.6.3. Lower Saxony Market Analysis
15.6.3.1. Introduction
15.6.3.2. Market Analysis and Forecast by Market Taxonomy
15.6.3.2.1. By Product
15.6.3.2.2. By Ingredient
15.6.3.2.3. By Application
15.6.3.2.4. By Distribution Channel
15.6.4. Hesse Market Analysis
15.6.4.1. Introduction
15.6.4.2. Market Analysis and Forecast by Market Taxonomy
15.6.4.2.1. By Product
15.6.4.2.2. By Ingredient
15.6.4.2.3. By Application
15.6.4.2.4. By Distribution Channel
16. Spain Market Analysis 2012 to 2022 and Forecast 2023 to 2033
16.1. Introduction
16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Market Taxonomy, 2012 to 2022
16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
16.3.1. By States
16.3.1.1. Madrid
16.3.1.2. Barcelona
16.3.1.3. Valencia
16.3.1.4. Seville
16.3.1.5. Rest of Spain
16.3.2. By Product
16.3.3. By Ingredient
16.3.4. By Application
16.3.5. By Distribution Channel
16.4. Market Attractiveness Analysis
16.4.1. By States
16.4.2. By Product
16.4.3. By Ingredient
16.4.4. By Application
16.4.5. By Distribution Channel
16.5. Drivers and Restraints - Impact Analysis
16.6. States Level Analysis & Forecast
16.6.1. Madrid Market Analysis
16.6.1.1. Introduction
16.6.1.2. Market Analysis and Forecast by Market Taxonomy
16.6.1.2.1. By Product
16.6.1.2.2. By Ingredient
16.6.1.2.3. By Application
16.6.1.2.4. By Distribution Channel
16.6.2. Barcelona Market Analysis
16.6.2.1. Introduction
16.6.2.2. Market Analysis and Forecast by Market Taxonomy
16.6.2.2.1. By Product
16.6.2.2.2. By Ingredient
16.6.2.2.3. By Application
16.6.2.2.4. By Distribution Channel
16.6.3. Valencia Market Analysis
16.6.3.1. Introduction
16.6.3.2. Market Analysis and Forecast by Market Taxonomy
16.6.3.2.1. By Product
16.6.3.2.2. By Ingredient
16.6.3.2.3. By Application
16.6.3.2.4. By Distribution Channel
16.6.4. Seville Market Analysis
16.6.4.1. Introduction
16.6.4.2. Market Analysis and Forecast by Market Taxonomy
16.6.4.2.1. By Product
16.6.4.2.2. By Ingredient
16.6.4.2.3. By Application
16.6.4.2.4. By Distribution Channel
17. Italy Market Analysis 2012 to 2022 and Forecast 2023 to 2033
17.1. Introduction
17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Market Taxonomy, 2012 to 2022
17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
17.3.1. By States
17.3.1.1. Rome
17.3.1.2. Abruzzo
17.3.1.3. Basilicata
17.3.1.4. Calabria
17.3.1.5. Rest of Italy
17.3.2. By Product
17.3.3. By Ingredient
17.3.4. By Application
17.3.5. By Distribution Channel
17.4. Market Attractiveness Analysis
17.4.1. By States
17.4.2. By Product
17.4.3. By Ingredient
17.4.4. By Application
17.4.5. By Distribution Channel
17.5. Drivers and Restraints - Impact Analysis
17.6. States Level Analysis & Forecast
17.6.1. Rome Market Analysis
17.6.1.1. Introduction
17.6.1.2. Market Analysis and Forecast by Market Taxonomy
17.6.1.2.1. By Product
17.6.1.2.2. By Ingredient
17.6.1.2.3. By Application
17.6.1.2.4. By Distribution Channel
17.6.2. Abruzzo Market Analysis
17.6.2.1. Introduction
17.6.2.2. Market Analysis and Forecast by Market Taxonomy
17.6.2.2.1. By Product
17.6.2.2.2. By Ingredient
17.6.2.2.3. By Application
17.6.2.2.4. By Distribution Channel
17.6.3. Basilicata Market Analysis
17.6.3.1. Introduction
17.6.3.2. Market Analysis and Forecast by Market Taxonomy
17.6.3.2.1. By Product
17.6.3.2.2. By Ingredient
17.6.3.2.3. By Application
17.6.3.2.4. By Distribution Channel
17.6.4. Calabria Market Analysis
17.6.4.1. Introduction
17.6.4.2. Market Analysis and Forecast by Market Taxonomy
17.6.4.2.1. By Product
17.6.4.2.2. By Ingredient
17.6.4.2.3. By Application
17.6.4.2.4. By Distribution Channel
18. France Market Analysis 2012 to 2022 and Forecast 2023 to 2033
18.1. Introduction
18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Market Taxonomy, 2012 to 2022
18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
18.3.1. By States
18.3.1.1. Auvergne - Rhône-Alpes
18.3.1.2. Bretagne (Brittany)
18.3.1.3. Bourgogne - Franche-Comté
18.3.1.4. Ile de France (Paris)
18.3.1.5. Rest of France
18.3.2. By Product
18.3.3. By Ingredient
18.3.4. By Application
18.3.5. By Distribution Channel
18.4. Market Attractiveness Analysis
18.4.1. By States
18.4.2. By Product
18.4.3. By Ingredient
18.4.4. By Application
18.4.5. By Distribution Channel
18.5. Drivers and Restraints - Impact Analysis
18.6. States Level Analysis & Forecast
18.6.1. Auvergne - Rhône-Alpes Market Analysis
18.6.1.1. Introduction
18.6.1.2. Market Analysis and Forecast by Market Taxonomy
18.6.1.2.1. By Product
18.6.1.2.2. By Ingredient
18.6.1.2.3. By Application
18.6.1.2.4. By Distribution Channel
18.6.2. Bretagne (Brittany) Market Analysis
18.6.2.1. Introduction
18.6.2.2. Market Analysis and Forecast by Market Taxonomy
18.6.2.2.1. By Product
18.6.2.2.2. By Ingredient
18.6.2.2.3. By Application
18.6.2.2.4. By Distribution Channel
18.6.3. Bourgogne - Franche-Comté Market Analysis
18.6.3.1. Introduction
18.6.3.2. Market Analysis and Forecast by Market Taxonomy
18.6.3.2.1. By Product
18.6.3.2.2. By Ingredient
18.6.3.2.3. By Application
18.6.3.2.4. By Distribution Channel
18.6.4. Ile de France (Paris)Market Analysis
18.6.4.1. Introduction
18.6.4.2. Market Analysis and Forecast by Market Taxonomy
18.6.4.2.1. By Product
18.6.4.2.2. By Ingredient
18.6.4.2.3. By Application
18.6.4.2.4. By Distribution Channel
19. BENELUX Market Analysis 2012 to 2022 and Forecast 2023 to 2033
19.1. Introduction
19.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Market Taxonomy, 2012 to 2022
19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
19.3.1. By Country
19.3.1.1. Belgium
19.3.1.2. Netherlands
19.3.1.3. Luxembourg
19.3.2. By Product
19.3.3. By Ingredient
19.3.4. By Application
19.3.5. By Distribution Channel
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Product
19.4.3. By Ingredient
19.4.4. By Application
19.4.5. By Distribution Channel
19.5. Drivers and Restraints - Impact Analysis
19.6. Country Level Analysis & Forecast
19.6.1. Belgium Market Analysis
19.6.1.1. Introduction
19.6.1.2. Market Analysis and Forecast by Market Taxonomy
19.6.1.2.1. By Product
19.6.1.2.2. By Ingredient
19.6.1.2.3. By Application
19.6.1.2.4. By Distribution Channel
19.6.2. Netherland Market Analysis
19.6.2.1. Introduction
19.6.2.2. Market Analysis and Forecast by Market Taxonomy
19.6.2.2.1. By Product
19.6.2.2.2. By Ingredient
19.6.2.2.3. By Application
19.6.2.2.4. By Distribution Channel
19.6.3. Luxemburg Market Analysis
19.6.3.1. Introduction
19.6.3.2. Market Analysis and Forecast by Market Taxonomy
19.6.3.2.1. By Product
19.6.3.2.2. By Ingredient
19.6.3.2.3. By Application
19.6.3.2.4. By Distribution Channel
20. Nordics Market Analysis 2012 to 2022 and Forecast 2023 to 2033
20.1. Introduction
20.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Market Taxonomy, 2012 to 2022
20.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
20.3.1. By Country
20.3.1.1. Denmark
20.3.1.2. Norway
20.3.1.3. Sweden
20.3.1.4. Finland
20.3.1.5. Rest of Nordics
20.3.2. By Product
20.3.3. By Ingredient
20.3.4. By Application
20.3.5. By Distribution Channel
20.4. Market Attractiveness Analysis
20.4.1. By Country
20.4.2. By Product
20.4.3. By Ingredient
20.4.4. By Application
20.4.5. By Distribution Channel
20.5. Drivers and Restraints - Impact Analysis
20.6. Country Level Analysis & Forecast
20.6.1. Denmark Market Analysis
20.6.1.1. Introduction
20.6.1.2. Market Analysis and Forecast by Market Taxonomy
20.6.1.2.1. By Product
20.6.1.2.2. By Ingredient
20.6.1.2.3. By Application
20.6.1.2.4. By Distribution Channel
20.6.2. Norway Market Analysis
20.6.2.1. Introduction
20.6.2.2. Market Analysis and Forecast by Market Taxonomy
20.6.2.2.1. By Product
20.6.2.2.2. By Ingredient
20.6.2.2.3. By Application
20.6.2.2.4. By Distribution Channel
20.6.3. Sweden Market Analysis
20.6.3.1. Introduction
20.6.3.2. Market Analysis and Forecast by Market Taxonomy
20.6.3.2.1. By Product
20.6.3.2.2. By Ingredient
20.6.3.2.3. By Application
20.6.3.2.4. By Distribution Channel
20.6.4. Finland Market Analysis
20.6.4.1. Introduction
20.6.4.2. Market Analysis and Forecast by Market Taxonomy
20.6.4.2.1. By Product
20.6.4.2.2. By Ingredient
20.6.4.2.3. By Application
20.6.4.2.4. By Distribution Channel
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Share Analysis of Top Players (%)
21.3. Market Concentration
21.4. Major Brands and Market Share per Brand
21.5. Market Presence Analysis
21.5.1. By Regional Footprint of Players
21.5.2. Product Footprint of Players
21.5.3. Channel Footprint of Players
22. Competition Analysis
22.1. Competition Benchmarking
22.2. Competition Dashboard
22.3. Branding and Promotional Strategies, By Key Players
22.4. Key Development Analysis
22.5. Competition Deep Dive
22.5.1. Galderma SA
22.5.1.1. Overview
22.5.1.2. Product Portfolio
22.5.1.3. Key Financials
22.5.1.4. SWOT Analysis
22.5.1.5. Key Developments
22.5.1.6. Sales Footprint
22.5.1.7. Strategy Overview
22.5.1.7.1. Marketing Strategy
22.5.1.7.2. Product Strategy
22.5.1.7.3. Channel Strategy
22.5.2. BioScience GmbH
22.5.2.1. Overview
22.5.2.2. Product Portfolio
22.5.2.3. Key Financials
22.5.2.4. SWOT Analysis
22.5.2.5. Key Developments
22.5.2.6. Sales Footprint
22.5.2.7. Strategy Overview
22.5.2.7.1. Marketing Strategy
22.5.2.7.2. Product Strategy
22.5.2.7.3. Channel Strategy
22.5.3. Croma Pharma
22.5.3.1. Overview
22.5.3.2. Product Portfolio
22.5.3.3. Key Financials
22.5.3.4. SWOT Analysis
22.5.3.5. Key Developments
22.5.3.6. Sales Footprint
22.5.3.7. Strategy Overview
22.5.3.7.1. Marketing Strategy
22.5.3.7.2. Product Strategy
22.5.3.7.3. Channel Strategy
22.5.4. Sinclair Pharma Plc.
22.5.4.1. Overview
22.5.4.2. Product Portfolio
22.5.4.3. Key Financials
22.5.4.4. SWOT Analysis
22.5.4.5. Key Developments
22.5.4.6. Sales Footprint
22.5.4.7. Strategy Overview
22.5.4.7.1. Marketing Strategy
22.5.4.7.2. Product Strategy
22.5.4.7.3. Channel Strategy
22.5.5. Zimmer Aesthetics
22.5.5.1. Overview
22.5.5.2. Product Portfolio
22.5.5.3. Key Financials
22.5.5.4. SWOT Analysis
22.5.5.5. Key Developments
22.5.5.6. Sales Footprint
22.5.5.7. Strategy Overview
22.5.5.7.1. Marketing Strategy
22.5.5.7.2. Product Strategy
22.5.5.7.3. Channel Strategy
22.5.6. Merz Pharma GmbH & Co. KgaA
22.5.6.1. Overview
22.5.6.2. Product Portfolio
22.5.6.3. Key Financials
22.5.6.4. SWOT Analysis
22.5.6.5. Key Developments
22.5.6.6. Sales Footprint
22.5.6.7. Strategy Overview
22.5.6.7.1. Marketing Strategy
22.5.6.7.2. Product Strategy
22.5.6.7.3. Channel Strategy
22.5.7. Teoxane Laboratories Inc.
22.5.7.1. Overview
22.5.7.2. Product Portfolio
22.5.7.3. Key Financials
22.5.7.4. SWOT Analysis
22.5.7.5. Key Developments
22.5.7.6. Sales Footprint
22.5.7.7. Strategy Overview
22.5.7.7.1. Marketing Strategy
22.5.7.7.2. Product Strategy
22.5.7.7.3. Channel Strategy
22.5.8. Adoderm GmbH
22.5.8.1. Overview
22.5.8.2. Product Portfolio
22.5.8.3. Key Financials
22.5.8.4. SWOT Analysis
22.5.8.5. Key Developments
22.5.8.6. Sales Footprint
22.5.8.7. Strategy Overview
22.5.8.7.1. Marketing Strategy
22.5.8.7.2. Product Strategy
22.5.8.7.3. Channel Strategy
22.5.9. LKC Pharma
22.5.9.1. Overview
22.5.9.2. Product Portfolio
22.5.9.3. Key Financials
22.5.9.4. SWOT Analysis
22.5.9.5. Key Developments
22.5.9.6. Sales Footprint
22.5.9.7. Strategy Overview
22.5.9.7.1. Marketing Strategy
22.5.9.7.2. Product Strategy
22.5.9.7.3. Channel Strategy
22.5.10. Celiraz Europe S.L.
22.5.10.1. Overview
22.5.10.2. Product Portfolio
22.5.10.3. Key Financials
22.5.10.4. SWOT Analysis
22.5.10.5. Key Developments
22.5.10.6. Sales Footprint
22.5.10.7. Strategy Overview
22.5.10.7.1. Marketing Strategy
22.5.10.7.2. Product Strategy
22.5.10.7.3. Channel Strategy
22.5.11. Allergan plc. (AbbVie)
22.5.11.1. Overview
22.5.11.2. Product Portfolio
22.5.11.3. Key Financials
22.5.11.4. SWOT Analysis
22.5.11.5. Key Developments
22.5.11.6. Sales Footprint
22.5.11.7. Strategy Overview
22.5.11.7.1. Marketing Strategy
22.5.11.7.2. Product Strategy
22.5.11.7.3. Channel Strategy
22.5.12. Suneva Medical, Inc
22.5.12.1. Overview
22.5.12.2. Product Portfolio
22.5.12.3. Key Financials
22.5.12.4. SWOT Analysis
22.5.12.5. Key Developments
22.5.12.6. Sales Footprint
22.5.12.7. Strategy Overview
22.5.12.7.1. Marketing Strategy
22.5.12.7.2. Product Strategy
22.5.12.7.3. Channel Strategy
22.5.13. Prollenium Medical Technologies Inc.
22.5.13.1. Overview
22.5.13.2. Product Portfolio
22.5.13.3. Key Financials
22.5.13.4. SWOT Analysis
22.5.13.5. Key Developments
22.5.13.6. Sales Footprint
22.5.13.7. Strategy Overview
22.5.13.7.1. Marketing Strategy
22.5.13.7.2. Product Strategy
22.5.13.7.3. Channel Strategy
22.5.14. Anika Therapeutics, Inc.
22.5.14.1. Overview
22.5.14.2. Product Portfolio
22.5.14.3. Key Financials
22.5.14.4. SWOT Analysis
22.5.14.5. Key Developments
22.5.14.6. Sales Footprint
22.5.14.7. Strategy Overview
22.5.14.7.1. Marketing Strategy
22.5.14.7.2. Product Strategy
22.5.14.7.3. Channel Strategy
22.5.15. DR. Korman
22.5.15.1. Overview
22.5.15.2. Product Portfolio
22.5.15.3. Key Financials
22.5.15.4. SWOT Analysis
22.5.15.5. Key Developments
22.5.15.6. Sales Footprint
22.5.15.7. Strategy Overview
22.5.15.7.1. Marketing Strategy
22.5.15.7.2. Product Strategy
22.5.15.7.3. Channel Strategy
23. Assumptions and Acronyms Used
24. Research Methodology
Explore Healthcare Insights
View Reports
Europe Dermal Fillers Market
